Pancytopenia. Pancytopenia
Conditions
Interventions
Intervention 1: Intervention group: The first group will be prescribed oral copper tablets at a dose of 300 micrograms 3 times a day,. Intervention 2: Control group: second group will be prescribed a
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Adult patients with bicytopenia or pancytopenia Adult patients with bicytopenia or pancytopenia and low serum copper levels Adult patients with bicytopenia or pancytopenia and no acute leukemia Adult patients with bicytopenia or pancytopenia and low serum copper levels who have clinical symptoms (weakness and lethargy, etc.). Age group 18 to 70 years
Exclusion criteria
Exclusion criteria: People with pancytopenia and low serum copper levels who are unwilling or uncooperative to receive oral copper supplements. People with pancytopenia and low serum copper levels who are unable to consume oral copper due to digestive disorders People with pancytopenia who die during treatment. People with pancytopenia who are diagnosed with cirrhosis during the diagnosis and treatment process Having acute leukemia People with high serum zinc levels
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the effect of copper and zinc supplementation on improving laboratory and clinical outcomes. Timepoint: Two to three weeks and one month after starting treatment. Method of measurement: Measuring WBC, RBC, PLT and clinical panel. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood group count test and clinical symptoms. Timepoint: Two to three weeks and one month after starting treatment. Method of measurement: Measuring WBC, RBC, PLT and clinical panel. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Faridfar
Artesh University of Medical Sciences
Outcome results
None listed